View Older Stories View More Recent Stories

Mar 31, 2020 04:12PM UNITY Biotechnology (UBX) Reports Complete Patient Enrollment in Phase 1b Study of UBX0101
Mar 31, 2020 04:05PM UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
Mar 30, 2020 05:20PM UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
Mar 11, 2020 04:05PM UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 3, 2020 04:05PM UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
Mar 2, 2020 04:30PM UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer
Feb 25, 2020 06:21AM UNITY Biotechnology (UBX) Provides Pipeline and Business Updates
Feb 25, 2020 06:00AM UNITY Biotechnology Provides Pipeline and Business Updates
Feb 24, 2020 04:05PM UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference
Nov 6, 2019 04:05PM UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates
Oct 31, 2019 08:12AM UNITY Biotechnology (UBX) Reports First Patient Dosed in Ph. 2 Study of UBX0101 in Osteoarthritis of the Knee
Oct 31, 2019 08:00AM UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
Oct 24, 2019 08:00AM UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting
Oct 23, 2019 08:00AM Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
Sep 20, 2019 08:00AM UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
Aug 27, 2019 08:00AM UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
Aug 7, 2019 04:05PM UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
Jul 30, 2019 05:10PM UNITY Biotechnology (UBX) Highlights Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
Jul 30, 2019 04:30PM UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
Jul 30, 2019 08:00AM UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results
Jun 18, 2019 07:04AM UNITY Biotechnology (UBX) Reports Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee
Jun 18, 2019 07:00AM UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee
May 29, 2019 04:05PM UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline
May 23, 2019 04:01PM UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences
May 8, 2019 04:05PM UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results
Apr 29, 2019 04:05PM UNITY Biotechnology, Inc. to Announce First Quarter 2019 Financial Results
Mar 6, 2019 08:00AM UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates
Mar 4, 2019 04:05PM UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference
Feb 27, 2019 04:05PM CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
Feb 25, 2019 04:05PM UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
Jan 22, 2019 04:19PM UNITY Biotechnology (UBX) Announces Expansion of Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of Knee
Jan 22, 2019 04:05PM UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee
Jan 3, 2019 04:52PM UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye
Dec 4, 2018 08:03AM UNITY Biotechnology (UBX) Names Margo Roberts PhD to Board
Dec 4, 2018 08:00AM UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors
Dec 3, 2018 05:30PM UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee
Nov 13, 2018 08:00AM UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence
Nov 7, 2018 04:05PM UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results
Oct 31, 2018 04:05PM UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results
Sep 24, 2018 04:05PM UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference
Sep 5, 2018 04:05PM UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
Aug 9, 2018 04:05PM UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results
Jul 31, 2018 04:05PM UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results
Jun 25, 2018 08:01AM UNITY Biotechnology Inc. (UBX) Reports First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee
Jun 25, 2018 08:00AM UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee
Jun 13, 2018 04:00PM UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes
Jun 7, 2018 05:00PM UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results
Jun 5, 2018 04:05PM UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
May 29, 2018 04:05PM UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results
View More Recent Stories View Older Stories